<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03393832</url>
  </required_header>
  <id_info>
    <org_study_id>H41227</org_study_id>
    <nct_id>NCT03393832</nct_id>
  </id_info>
  <brief_title>Oral Care in Infants With Gastroschisis</brief_title>
  <official_title>Oral Care: An Important Adjunctive Therapy in Infants With Gastroschisis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastroschisis is a rare abdominal wall defect. Though survival rate is high, there are
      significant complications related to feeding intolerance and infections. Recently, oral care
      with breast milk has been studied in extremely premature infants and has been shown to
      improve both feeding tolerance and protect against infection. Though only studied in
      premature infants, it is likely that other populations of patients can benefit form oral care
      as well. This study is a randomized controlled trial aimed to demonstrate the benefits of
      oral care with all breast milk (either mother's milk or pasteurized donor breast milk) in
      infants with gastroschisis. Additionally, the investigators will evaluate how oral care with
      all breast milk affects the intestinal bacterial environment and how oral care with all
      breast milk affects the secretion of certain proteins from the salivary gland.

      Primary hypothesis: The primary objective is to compare the magnitude of increase in
      intestinal microbiota alpha diversity over a four week period between the two study arms
      using a paired analysis.

      Secondary hypothesis:

        -  Oral care with breast milk will decrease the days to start enteral feeds after primary
           surgical closure inpatients with gastroschisis.

        -  Oral care with breast milk will decrease the days to reach full enteral feeds of 140
           cc/kg/day in patients with gastroschisis.

        -  Oral care with breast milk will decrease length of stay in patients with gastroschisis.

        -  Oral care with breast milk will increase secretion of certain proteins, such as vascular
           endothelial growth factor, from the salivary gland.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breast milk is recommended for most infants by the American Academy of Pediatrics as there
      are multiple benefits. However, some infants, such as extremely premature infants, are unable
      to receive enteral nutrition for a variety of clinical reasons. In order provide these
      infants with some of the benefits of mother's milk, a novel adjunctive therapy called oral
      care has been developed. Oral care consists of applying mother's breast milk to the buccal
      mucosa. Oral care has been studied in the premature infant population and been shown to
      improve both feeding tolerance and to provide immune protection. Although only studied in the
      premature population, many institutions have adopted oral care as a standard of care for all
      infants as oral care poses minimal risk to the patient and has many potential benefits.
      Gastroschisis is a rare abdominal wall defect. Although the survival rate for infants with
      gastroschisis is high, there are significant morbidities related to feeding intolerance and
      infection. The investigators believe that this population of patients will also benefit from
      oral care.

      The mechanism by which oral care works is not completely understood. It is theorized that
      oral care stimulates the oropharyngeal-lymphoid tissue in the buccal mucosa. Additional
      mechanisms include alteration of the intestinal microbiome. The intestinal microbiome is the
      millions of microorganisms that line the intestine. Normally, there is a mutually beneficial
      relationship. The intestinal microbiome is altered by many factors, including gestational
      age, antibiotic use, type of delivery, etc. Alterations in the microbiome can be detrimental
      and cause severe diseases such as necrotizing enterocolitis. Thus, far studies have shown
      that oral care alters the oral microbiome to include more healthy bacteria. The investigators
      believe that oral care with breast milk will be associated with a more diverse fecal
      microbiota. Finally, the investigators will evaluate a novel mechanism by which the
      investigators believe oral care is protective; via increased salivary gland secretion of
      certain proteins important for healing. In particular, saliva contains vascular endothelial
      growth factor, which is important for palatal wound healing and alimentary tract healing.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 14, 2017</start_date>
  <completion_date type="Anticipated">April 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Pilot, randomized controlled trial</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Oral care syringes will be covered with yellow tape.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Microbiome Outcome</measure>
    <time_frame>4 weeks</time_frame>
    <description>The primary objective is to compare the magnitude of increase in intestinal microbiota alpha diversity over a four week period between the two study arms using a paired analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcome 1</measure>
    <time_frame>The current average time to start feeds after surgical closure is 15 days.</time_frame>
    <description>The first secondary objective is to compare the days to start enteral feeds after primary surgical closure between the two study arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcome 2</measure>
    <time_frame>The current average time to reach full enteral feeds is 105 days.</time_frame>
    <description>The second secondary objective is to compare days to reach full enteral feeds of 140 cc/kg/day between the two study arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcome 3</measure>
    <time_frame>The current average length of stay is 70 days.</time_frame>
    <description>The third secondary objective is to compare length of stay between the two study arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary Gland Outcome</measure>
    <time_frame>6 weeks</time_frame>
    <description>The final secondary objective is to compare levels of salivary proteins between the two study arms using either ELISA or Luminex Mulitplex assays.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastroschisis</condition>
  <arm_group>
    <arm_group_label>Oral Care with Sterile Water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The Placebo group will receive oral care with sterile water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Care with all Breast Milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Experimental group will receive oral care with all breast milk. Mother's milk will be used first. When mother's milk is not available, pasteurized donor breast milk will be used.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral Care with sterile water</intervention_name>
    <description>Administration of 0.2 ml of sterile water to buccal mucosa, every 3-4 hours for 4 weeks beginning within 72 hours of birth.</description>
    <arm_group_label>Oral Care with Sterile Water</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral Care with all breast milk</intervention_name>
    <description>Administration of 0.2 ml of breast milk (either mother's milk or pasteurized donor breast milk) to buccal mucosa, every 3-4 hours for 4 weeks beginning within 72 hours of birth.</description>
    <arm_group_label>Oral Care with all Breast Milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ Infants with a primary diagnosis of gastroschisis

        Exclusion Criteria:

          -  Gestational age less than 30 weeks

          -  Birth weight less than 1,000 g

          -  Other major congenital anomalies or clinically significant heart disease

          -  First dose of oral care greater than 72 hours after birth

          -  Early transfer to another institution
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amy B Hair, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeth J Sager, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy B Hair, MD</last_name>
    <phone>832-826-1380</phone>
    <email>abhair@bcm.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elizabeth J Sager, MD</last_name>
    <phone>832-826-1380</phone>
    <email>elizabeth.sager@bcm.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Texas Children's Hospital Fetal Center and Newborn Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>770230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy B Hair, MD</last_name>
      <phone>832-826-1380</phone>
      <email>abhair@bcm.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Elizabeth J Sager, MD</last_name>
      <phone>832-826-1380</phone>
      <email>elizabeth.sager@bcm.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2012 Mar;129(3):e827-41. doi: 10.1542/peds.2011-3552. Epub 2012 Feb 27. Review.</citation>
    <PMID>22371471</PMID>
  </reference>
  <reference>
    <citation>Rodriguez NA, Meier PP, Groer MW, Zeller JM. Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives. J Perinatol. 2009 Jan;29(1):1-7. doi: 10.1038/jp.2008.130. Epub 2008 Sep 4. Review.</citation>
    <PMID>18769379</PMID>
  </reference>
  <reference>
    <citation>Gephart SM, Weller M. Colostrum as oral immune therapy to promote neonatal health. Adv Neonatal Care. 2014 Feb;14(1):44-51. doi: 10.1097/ANC.0000000000000052. Review.</citation>
    <PMID>24472888</PMID>
  </reference>
  <reference>
    <citation>Rodriguez NA, Vento M, Claud EC, Wang CE, Caplan MS. Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial. Trials. 2015 Oct 12;16:453. doi: 10.1186/s13063-015-0969-6.</citation>
    <PMID>26458907</PMID>
  </reference>
  <reference>
    <citation>Lee J, Kim HS, Jung YH, Choi KY, Shin SH, Kim EK, Choi JH. Oropharyngeal colostrum administration in extremely premature infants: an RCT. Pediatrics. 2015 Feb;135(2):e357-66. doi: 10.1542/peds.2014-2004.</citation>
    <PMID>25624376</PMID>
  </reference>
  <reference>
    <citation>Thibeau S, Boudreaux C. Exploring the use of mothers' own milk as oral care for mechanically ventilated very low-birth-weight preterm infants. Adv Neonatal Care. 2013 Jun;13(3):190-7. doi: 10.1097/ANC.0b013e318285f8e2.</citation>
    <PMID>23722491</PMID>
  </reference>
  <reference>
    <citation>Rodriguez NA, Caplan MS. Oropharyngeal administration of mother's milk to prevent necrotizing enterocolitis in extremely low-birth-weight infants: theoretical perspectives. J Perinat Neonatal Nurs. 2015 Jan-Mar;29(1):81-90. doi: 10.1097/JPN.0000000000000087. Review.</citation>
    <PMID>25633403</PMID>
  </reference>
  <reference>
    <citation>McCallie KR, Lee HC, Mayer O, Cohen RS, Hintz SR, Rhine WD. Improved outcomes with a standardized feeding protocol for very low birth weight infants. J Perinatol. 2011 Apr;31 Suppl 1:S61-7. doi: 10.1038/jp.2010.185.</citation>
    <PMID>21448207</PMID>
  </reference>
  <reference>
    <citation>Seigel JK, Smith PB, Ashley PL, Cotten CM, Herbert CC, King BA, Maynor AR, Neill S, Wynn J, Bidegain M. Early administration of oropharyngeal colostrum to extremely low birth weight infants. Breastfeed Med. 2013 Dec;8(6):491-5. doi: 10.1089/bfm.2013.0025. Epub 2013 Jun 27.</citation>
    <PMID>23805944</PMID>
  </reference>
  <reference>
    <citation>Rodriguez NA, Meier PP, Groer MW, Zeller JM, Engstrom JL, Fogg L. A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother's colostrum to extremely low-birth-weight infants. Adv Neonatal Care. 2010 Aug;10(4):206-12. doi: 10.1097/ANC.0b013e3181e94133.</citation>
    <PMID>20697221</PMID>
  </reference>
  <reference>
    <citation>Spinelli M, Frigerio A, Montali L, Fasolo M, Spada MS, Mangili G. 'I still have difficulties feeling like a mother': The transition to motherhood of preterm infants mothers. Psychol Health. 2016;31(2):184-204. doi: 10.1080/08870446.2015.1088015. Epub 2015 Oct 8.</citation>
    <PMID>26359768</PMID>
  </reference>
  <reference>
    <citation>Durfee SM, Benson CB, Adams SR, Ecker J, House M, Jennings R, Katz D, Pettigrew C, Wolfberg A. Postnatal outcome of fetuses with the prenatal diagnosis of gastroschisis. J Ultrasound Med. 2013 Mar;32(3):407-12.</citation>
    <PMID>23443180</PMID>
  </reference>
  <reference>
    <citation>O'Connell RV, Dotters-Katz SK, Kuller JA, Strauss RA. Gastroschisis: A Review of Management and Outcomes. Obstet Gynecol Surv. 2016 Sep;71(9):537-44. doi: 10.1097/OGX.0000000000000344. Review.</citation>
    <PMID>27640608</PMID>
  </reference>
  <reference>
    <citation>Gamba P, Midrio P. Abdominal wall defects: prenatal diagnosis, newborn management, and long-term outcomes. Semin Pediatr Surg. 2014 Oct;23(5):283-90. doi: 10.1053/j.sempedsurg.2014.09.009. Epub 2014 Sep 4. Review.</citation>
    <PMID>25459013</PMID>
  </reference>
  <reference>
    <citation>Shah SK, Aroom KR, Walker PA, Xue H, Jimenez F, Gill BS, Cox CS Jr, Moore-Olufemi SD. Effects of nonocclusive mesenteric hypertension on intestinal function: implications for gastroschisis-related intestinal dysfunction. Pediatr Res. 2012 Jun;71(6):668-74. doi: 10.1038/pr.2012.20. Epub 2012 Feb 14.</citation>
    <PMID>22476046</PMID>
  </reference>
  <reference>
    <citation>Dalton BG, Gonzalez KW, Reddy SR, Hendrickson RJ, Iqbal CW. Improved outcomes for inborn babies with uncomplicated gastroschisis. J Pediatr Surg. 2017 Jul;52(7):1132-1134. doi: 10.1016/j.jpedsurg.2016.12.003. Epub 2016 Dec 18.</citation>
    <PMID>28017414</PMID>
  </reference>
  <reference>
    <citation>Hook-Dufresne DM, Yu X, Bandla V, Imseis E, Moore-Olufemi SD. The economic burden of gastroschisis: costs of a birth defect. J Surg Res. 2015 May 1;195(1):16-20. doi: 10.1016/j.jss.2015.01.036. Epub 2015 Jan 28.</citation>
    <PMID>25703160</PMID>
  </reference>
  <reference>
    <citation>Sydorak RM, Nijagal A, Sbragia L, Hirose S, Tsao K, Phibbs RH, Schmitt SK, Lee H, Farmer DL, Harrison MR, Albanese CT. Gastroschisis: small hole, big cost. J Pediatr Surg. 2002 Dec;37(12):1669-72.</citation>
    <PMID>12483626</PMID>
  </reference>
  <reference>
    <citation>Balgi S, Singhal S, Mueller G, Batton B. Feeding Intolerance and Poor Growth in Infants with Gastroschisis: Longitudinal Experience with Consecutive Patients over Thirteen Years. J Neonatal Surg. 2015 Oct 1;4(4):42. eCollection 2015 Oct-Dec.</citation>
    <PMID>26500852</PMID>
  </reference>
  <reference>
    <citation>Lao OB, Healey PJ, Perkins JD, Reyes JD, Goldin AB. Outcomes in children with intestinal failure following listing for intestinal transplant. J Pediatr Surg. 2010 Jan;45(1):100-7; discussion 107. doi: 10.1016/j.jpedsurg.2009.10.019.</citation>
    <PMID>20105588</PMID>
  </reference>
  <reference>
    <citation>Patel P, Bhatia J. Total parenteral nutrition for the very low birth weight infant. Semin Fetal Neonatal Med. 2017 Feb;22(1):2-7. doi: 10.1016/j.siny.2016.08.002. Epub 2016 Aug 27. Review. Erratum in: Semin Fetal Neonatal Med. 2018 Feb;23 (1):75.</citation>
    <PMID>27576106</PMID>
  </reference>
  <reference>
    <citation>Stevens TP, Schulman J. Evidence-based approach to preventing central line-associated bloodstream infection in the NICU. Acta Paediatr. 2012 Apr;101(464):11-6. doi: 10.1111/j.1651-2227.2011.02547.x. Review.</citation>
    <PMID>22404886</PMID>
  </reference>
  <reference>
    <citation>Mahieu LM, De Muynck AO, Ieven MM, De Dooy JJ, Goossens HJ, Van Reempts PJ. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. J Hosp Infect. 2001 Jun;48(2):108-16.</citation>
    <PMID>11428877</PMID>
  </reference>
  <reference>
    <citation>Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, Venick R, Rhee S, Sudan D, Mercer D, Martinez JA, Carter BA, Soden J, Horslen S, Rudolph JA, Kocoshis S, Superina R, Lawlor S, Haller T, Kurs-Lasky M, Belle SH; Pediatric Intestinal Failure Consortium. Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium. J Pediatr. 2012 Oct;161(4):723-8.e2. doi: 10.1016/j.jpeds.2012.03.062. Epub 2012 May 11.</citation>
    <PMID>22578586</PMID>
  </reference>
  <reference>
    <citation>Miranda da Silva Alves F, Miranda ME, de Aguiar MJ, Bouzada Viana MC. Nutritional management and postoperative prognosis of newborns submitted to primary surgical repair of gastroschisis. J Pediatr (Rio J). 2016 May-Jun;92(3):268-75. doi: 10.1016/j.jped.2015.07.009. Epub 2016 Feb 2.</citation>
    <PMID>26844392</PMID>
  </reference>
  <reference>
    <citation>Aljahdali A, Mohajerani N, Skarsgard ED; Canadian Pediatric Surgery Network (CAPSNet). Effect of timing of enteral feeding on outcome in gastroschisis. J Pediatr Surg. 2013 May;48(5):971-6. doi: 10.1016/j.jpedsurg.2013.02.014.</citation>
    <PMID>23701769</PMID>
  </reference>
  <reference>
    <citation>Gulack BC, Laughon MM, Clark RH, Burgess T, Robinson S, Muhammad A, Zhang A, Davis A, Morton R, Chu VH, Arnold CJ, Hornik CP, Smith PB. Enteral Feeding with Human Milk Decreases Time to Discharge in Infants following Gastroschisis Repair. J Pediatr. 2016 Mar;170:85-9. doi: 10.1016/j.jpeds.2015.11.046. Epub 2015 Dec 15.</citation>
    <PMID>26703875</PMID>
  </reference>
  <reference>
    <citation>Torrazza RM, Neu J. The altered gut microbiome and necrotizing enterocolitis. Clin Perinatol. 2013 Mar;40(1):93-108. doi: 10.1016/j.clp.2012.12.009. Review.</citation>
    <PMID>23415266</PMID>
  </reference>
  <reference>
    <citation>Min YW, Rhee PL. The Role of Microbiota on the Gut Immunology. Clin Ther. 2015 May 1;37(5):968-75. doi: 10.1016/j.clinthera.2015.03.009. Epub 2015 Apr 4. Review.</citation>
    <PMID>25846321</PMID>
  </reference>
  <reference>
    <citation>Neu J, Pammi M. Pathogenesis of NEC: Impact of an altered intestinal microbiome. Semin Perinatol. 2017 Feb;41(1):29-35. doi: 10.1053/j.semperi.2016.09.015. Epub 2016 Dec 13. Review.</citation>
    <PMID>27986328</PMID>
  </reference>
  <reference>
    <citation>Westerbeek EA, van den Berg A, Lafeber HN, Knol J, Fetter WP, van Elburg RM. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr. 2006 Jun;25(3):361-8. Epub 2006 May 4. Review.</citation>
    <PMID>16677741</PMID>
  </reference>
  <reference>
    <citation>Liu S. The Development of Our Organ of Other Kinds-The Gut Microbiota. Front Microbiol. 2016 Dec 23;7:2107. doi: 10.3389/fmicb.2016.02107. eCollection 2016.</citation>
    <PMID>28066404</PMID>
  </reference>
  <reference>
    <citation>Meropol SB, Edwards A. Development of the infant intestinal microbiome: A bird's eye view of a complex process. Birth Defects Res C Embryo Today. 2015 Dec;105(4):228-39. doi: 10.1002/bdrc.21114. Epub 2015 Dec 11. Review.</citation>
    <PMID>26663826</PMID>
  </reference>
  <reference>
    <citation>Magne F, Suau A, Pochart P, Desjeux JF. Fecal microbial community in preterm infants. J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):386-92. Review.</citation>
    <PMID>16205503</PMID>
  </reference>
  <reference>
    <citation>Sohn K, Kalanetra KM, Mills DA, Underwood MA. Buccal administration of human colostrum: impact on the oral microbiota of premature infants. J Perinatol. 2016 Feb;36(2):106-11. doi: 10.1038/jp.2015.157. Epub 2015 Dec 10.</citation>
    <PMID>26658119</PMID>
  </reference>
  <reference>
    <citation>Keswani SG, Balaji S, Le LD, Leung A, Parvadia JK, Frischer J, Yamano S, Taichman N, Crombleholme TM. Role of salivary vascular endothelial growth factor (VEGF) in palatal mucosal wound healing. Wound Repair Regen. 2013 Jul-Aug;21(4):554-62. doi: 10.1111/wrr.12065. Epub 2013 Jun 11.</citation>
    <PMID>23758212</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2018</study_first_submitted>
  <study_first_submitted_qc>January 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2018</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Amy Hair</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Oral care</keyword>
  <keyword>Oropharyngeal mother's milk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroschisis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

